Caplin Point Laboratories Limited (CAPLIPOINT) Stock Statistics & Valuation Metrics

Caplin Point Laboratories Limited has a market cap or net worth of ₹157.33B. The enterprise value is ₹152.01B.

Caplin Point Laboratories Limited has 76,011,696 shares outstanding. The number of shares has decreased by -2.65% in one year.

Caplin Point Laboratories Limited’s return on equity (ROE) is 0.19 and return on invested capital (ROIC) is 25.10%.

The current PE Ratio of {name} is {pe}. {name}’s PEG ratio is {priceToEarningsGrowthRatio}.

In the last 12 months, Caplin Point Laboratories Limited had revenue of 19.37B and earned 5.36B in profits. Earnings per share was 70.57.

In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.

Caplin Point Laboratories Limited pays an annual dividend of ₹5.5, resulting in a dividend yield of 0.29%

Caplin Point Laboratories Limited upcoming earnings date is Aug 1, 2025, TBA (Confirmed).

Caplin Point Laboratories Limited as a current ratio of 6.97, with Debt / Equity ratio of 0.18%

In the past 12 months, Caplin Point Laboratories Limited has paid 1.36B in taxes.

Caplin Point Laboratories Limited EV to EBITDA ratio is 22.43, with an EV/FCF ratio of 60.25.

Caplin Point Laboratories Limited has ₹9.03B in cash and marketable securities with ₹50.20M in debt, giving a net cash position of -₹8.98B billion.

Gross margin is 57.32%, with operating margin of 47.08%, and net profit margin of 27.68%.

The average price target for Caplin Point Laboratories Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―